76 phenotypes from 7 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Il15m1Hwata/Il15m1Hwata Not Specified	abnormal interleukin secretion	J:184570
	abnormal NK T cell number	J:184570
	decreased interferon-gamma secretion	J:184570
	decreased NK cell number	J:184570
	decreased NK T cell number	J:184570
Il15tm1.1Iku/Il15+ B6.Cg-Il15tm1.1Iku	normal immune system phenotype	J:206571
Il15tm1b(EUCOMM)Hmgu/Il15tm1b(EUCOMM)Hmgu C57BL/6N-Il15tm1b(EUCOMM)Hmgu/H	enlarged heart	J:211773
	impaired glucose tolerance	J:211773
	increased grip strength	J:211773
	limb grasping	J:211773
Il15tm1Imx/Il15tm1Imx C57BL/6-Il15tm1Imx	abnormal dendritic cell physiology	J:123902
Il15tm1Imx/Il15tm1Imx C57BL/6-Il15tm1Imx/Tac	abnormal CD8-positive, alpha-beta T cell differentiation	J:111786
	abnormal thymus cell ratio	J:111786
	decreased CD8-positive, alpha-beta T cell number	J:111786
Il15tm1Imx/Il15tm1Imx involves: C57BL/6	abnormal CD8-positive, alpha-beta T cell physiology	J:95221
	abnormal cytokine secretion	J:97620
	abnormal decidualization	J:84009
	abnormal immune system morphology	J:60915
	abnormal immune system physiology	J:60915
	abnormal lymphocyte morphology	J:60915
	abnormal susceptibility to infection	J:60915
	abnormal uterine artery morphology	J:84009
	absent uterine NK cells	J:84009
	decreased body weight	J:84009
	decreased CD8-positive, alpha-beta T cell number	J:60915, J:113408
	decreased CD8-positive, gamma-delta intraepithelial T cell number	J:155298
	decreased dendritic cell number	J:97620
	decreased IgG level	J:97620
	decreased IgM level	J:97620
	decreased immunoglobulin level	J:97620
	decreased interferon-gamma secretion	J:97620
	decreased interleukin-12 secretion	J:97620
	decreased memory T cell number	J:132730
	decreased NK cell number	J:60915, J:132730, J:142654
	decreased regulatory T cell number	J:208318
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:84009
	decreased susceptibility to type IV hypersensitivity reaction	J:87137
	impaired natural killer cell mediated cytotoxicity	J:97620
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:97038
	increased susceptibility to parasitic infection	J:97620
	increased susceptibility to Poxviridae infection induced morbidity/mortality	J:60915
	small lymph nodes	J:60915
Tg(ACTA1-Il15)10941Lsq/0 involves: C3H * C57BL/6	abnormal interleukin level	J:145611
	normal adipose tissue phenotype	J:145611
	normal growth/size/body region phenotype	J:145611
	normal hematopoietic system phenotype	J:145611
	normal homeostasis/metabolism phenotype	J:145611
	normal skeleton phenotype	J:145611
Tg(ACTA1-Il15*)11650Lsq/0 involves: C3H * C57BL/6	abnormal body weight	J:145611
	abnormal interleukin level	J:145611
	decreased abdominal adipose tissue amount	J:145611
	decreased body weight	J:145611
	decreased circulating leptin level	J:145611
	decreased extensor digitorum longus weight	J:145611
	decreased fat cell size	J:145611
	decreased percent body fat/body weight	J:145611
	normal hematopoietic system phenotype	J:145611
	increased bone mineral content	J:145611
	increased circulating interleukin-15 level	J:145611
	increased lean body mass	J:145611
Tg(H2-D-Il15)3304Clgr/? FVB/N-Tg(H2-D-Il15)3304Clgr	abnormal inflammatory response	J:67478
	abnormal liver morphology	J:67478
	abnormal lung morphology	J:67478
	abnormal lymphocyte physiology	J:67478
	abnormal T cell morphology	J:67478
	abnormal T cell subpopulation ratio	J:67478
	alopecia	J:67478
	dermatitis	J:67478
	enlarged liver	J:67478
	enlarged lymph nodes	J:67478
	enlarged spleen	J:67478
	epidermal hyperplasia	J:67478
	hair follicle degeneration	J:67478
	hyperkeratosis	J:67478
	increased bone marrow cell number	J:67478
	increased leukemia incidence	J:67478, J:97873
	increased lymphocyte cell number	J:67478
	increased memory T cell number	J:67478
	increased NK cell number	J:67478
	increased spleen white pulp amount	J:67478
	premature death	J:67478
	spontaneous skin ulceration	J:67478